{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:29:09Z","timestamp":1792459749898,"version":"4.5.0"},"reference-count":184,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.1080\/14787210.2026.2646192","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:57:57Z","timestamp":1773482277000},"page":"239-257","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Current status of immunomodulatory therapies in adult sepsis patients: where do we stand?"],"prefix":"10.1080","volume":"24","author":[{"given":"Dimitra","family":"Papatheodosiou","sequence":"first","affiliation":[{"name":"National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Tsoukas","sequence":"additional","affiliation":[{"name":"McGill University","place":["Montreal, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/epidemiologia5030032"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005337"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000089945.69588.18"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000145229.59014.6C"},{"key":"e_1_3_4_9_1","first-page":"37","article-title":"Immunomodulatory effect of extracorporeal hemocorrection in patients with surgical sepsis","volume":"3","author":"Borovkova NV","year":"2009","unstructured":"Borovkova NV, Aleksandrova IV, Khvatov VB, et al. Immunomodulatory effect of extracorporeal hemocorrection in patients with surgical sepsis. Anesteziol Reanimatol. 2009;3:37\u201340.","journal-title":"Anesteziol Reanimatol"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/590500"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441001"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202290"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00676-0"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01499-z"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104355"},{"key":"e_1_3_4_17_1","unstructured":"EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation | European Medicines Agency [Internet]. [cited 2026 Feb 9]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-endorses-use-dexamethasone-covid-19-patients-oxygen-or-mechanical-ventilation"},{"key":"e_1_3_4_18_1","unstructured":"Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19 [Internet]. [cited 2026 Feb 9]. Available from: https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/0"},{"key":"e_1_3_4_19_1","unstructured":"COVID-19: corticosteroids (guidelines) | right decisions [internet]. Scot.nhs.uk. 2023 [cited 2026 Feb 9]. Available from: https:\/\/rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/adult-therapeutic-guidelines\/covid-19-coronavirus\/covid-19-treatment-guidelines\/covid-19-corticosteroids-guidelines\/"},{"key":"e_1_3_4_20_1","unstructured":"COVID-19 & EUA Treatment Info | ACTEMRA\u00ae (tocilizumab) [Internet]. actemra; 2025 [cited 2025 Oct 26]. Available from: https:\/\/www.actemrahcp.com\/covid-19.html"},{"key":"e_1_3_4_21_1","unstructured":"EMA recommends approval for use of RoActemra in adults with severe COVID-19 | European medicines Agency (EMA) [internet]. European Medicines Agency (EMA); 2021 [cited 2026 Feb 9]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-use-roactemra-adults-severe-covid-19"},{"key":"e_1_3_4_22_1","unstructured":"COVID-19: tocilizumab (guidelines) | right decisions [Internet]. Scot.nhs.uk; 2023 [cited 2025 Oct 26]. Available from: https:\/\/rightdecisions.scot.nhs.uk\/tam-treatments-and-medicines-nhs-highland\/adult-therapeutic-guidelines\/covid-19-coronavirus\/covid-19-treatment-guidelines\/covid-19-tocilizumab-guidelines\/"},{"key":"e_1_3_4_23_1","unstructured":"EMA recommends approval for use of kineret in adults with COVID-19 | European medicines Agency (EMA) [Internet]. European Medicines Agency (EMA); 2021 [cited 2025 Oct 26]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-use-kineret-adults-covid-19"},{"key":"e_1_3_4_24_1","unstructured":"Using machine learning to identify a suitable patient population [Internet]. U.S. Food and Drug Administration; 2024 [cited 2025 Oct 26]. Available from: https:\/\/www.fda.gov\/drugs\/spotlight-cder-science\/using-machine-learning-identify-suitable-patient-population-anakinra-treatment-covid-19-under"},{"key":"e_1_3_4_25_1","unstructured":"Clinicaltrials.gov. 2026 [cited 2026 Feb 9]. Available from: https:\/\/clinicaltrials.gov\/"},{"key":"e_1_3_4_26_1","unstructured":"The UK\u2019s Clinical Study Registry. 2026 [cited 2026 Feb 9]. Available from: https:\/\/www.isrctn.com\/"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30294-1"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(16)00046-1"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1419OC"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41435-018-0030-3"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70097-9"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0930-5"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0204-8"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100817"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071836"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2013.110"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105414"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07065-0"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.26152"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.5791"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066608326970"},{"issue":"26","key":"e_1_3_4_42_1","first-page":"162","article-title":"Immunotherapy of sepsis syndrome: a comparison of the available treatments","volume":"69","author":"Fisher CJ","year":"1991","unstructured":"Fisher CJ, Bellingan G. Immunotherapy of sepsis syndrome: a comparison of the available treatments. Klin Wochenschr. 1991;69(Suppl 26):162\u2013167.","journal-title":"Klin Wochenschr"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200003000-00006"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00303-8"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.5935\/0103-507X.20200063"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00170"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06289-8"},{"issue":"13","key":"e_1_3_4_48_1","first-page":"1","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19","volume":"324","author":"Sterne JA","year":"2020","unstructured":"Sterne JA, Murthy S, Diaz JV, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19. JAMA. 2020;324(13):1\u201313.","journal-title":"JAMA"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-03422-3"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.37201\/req\/091.2020"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02215-6"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27357"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885066621994057"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2245"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2021.01081"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab212"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-10864-8"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705835"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705716"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31819df06b"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215145"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04108-8"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255644"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-07861-w"},{"issue":"3","key":"e_1_3_4_66_1","first-page":"221","article-title":"Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials","volume":"13","author":"Smit JM","year":"2025","unstructured":"Smit JM, Van Der Zee PA, Stoof SC, et al. Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. Lancet. 2025;13(3):221\u2013233.","journal-title":"Lancet"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-025-07912-2"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.04.009"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-021-01507-5"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222488"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106241"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac153"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00377-5"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100433"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.02.027"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00081-3"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.6615"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2030340"},{"issue":"1","key":"e_1_3_4_81_1","first-page":"1","article-title":"Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia","volume":"181","author":"Hermine O","year":"2020","unstructured":"Hermine O, Mariette X, Tharaux PL, et al. Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia. JAMA Intern Med. 2020;181(1):1\u20139.","journal-title":"JAMA Intern Med"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028700"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-025-02506-y"},{"key":"e_1_3_4_84_1","unstructured":"IDSA. 2025 [cited 2026 Feb 9]. Available from: https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004174"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10060692"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30404-5"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02897-4"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66125"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001126"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.01.024"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.11.006"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0295838"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30556-7"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08908-8"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1995.01430070061012"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199707000-00011"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199401000-00008"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199707000-00010"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001402"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14029"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200001000-00002"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98960"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009005"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154330"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200903-0363OC"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211323"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06339-1"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05704-z"},{"issue":"1","key":"e_1_3_4_110_1","first-page":"69","article-title":"Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients","volume":"97","author":"Cometta A","year":"1994","unstructured":"Cometta A, Baumgartner JD, Glauser MP. Polyclonal intravenous immune globulin for prevention and treatment of infections in critically ill patients. Clin Exp Immunol. 1994;97(Suppl 1):69\u201372.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001090.pub2"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4786-0"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000157302.69125.f8"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1086\/376630"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc10607"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188859"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc13073"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144645"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2011.05.012"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5143-7"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04719-9"},{"key":"e_1_3_4_122_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000577"},{"key":"e_1_3_4_123_1","unstructured":"US Food and Drug Administration. FDA authorizes Gohibic (vilobelimab) injection for the treatment of COVID-19. FDA; 2023 [cited 2026 Feb 9]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-authorizes-gohibic-vilobelimab-injection-treatment-covid-19"},{"key":"e_1_3_4_124_1","unstructured":"Gohibic | European medicines Agency (EMA) [Internet]. European Medicines Agency (EMA); 2024 [cited 2026 Feb 9]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gohibic#authorisation-details"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.05.006"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30341-6"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00297-1"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06537-5"},{"key":"e_1_3_4_129_1","unstructured":"Article review: the AdrenOSS-2 phase 2a biomarker-guided trial [internet]. ESICM; 2022 [cited 2026 Feb 9]. Available from: https:\/\/www.esicm.org\/article-review-non-neutralising-adrenomedullin-antibody-adrecizumab-in-septic-shock-patients\/"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316610"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(02)00330-2"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc11159"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.14283"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07271-w"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2200644"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-1-200501040-00110"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1130214"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13063-x"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156277"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.07.016"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903151"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTCCM-D-24-00015"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1177\/03913988221107947"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220444"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000002121"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.14618"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5463-7"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04690-5"},{"key":"e_1_3_4_149_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2026 Feb 9]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03901807"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1159\/000491744"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04533-3"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2077-y"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.11.003"},{"key":"e_1_3_4_154_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15534"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.141.2.150"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.14059"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04795-x"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-002-1410-7"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.02.029"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00158-3"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.03.062"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.010"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08819-3"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1007948"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.5208"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.07.009"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1823-5"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082583"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718191"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003685"},{"key":"e_1_3_4_171_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06669403?term=NCT06669403"},{"key":"e_1_3_4_172_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6].Available from: https:\/\/clinicaltrials.gov\/study\/NCT06562803?term=NCT06562803"},{"key":"e_1_3_4_173_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06504316?term=NCT06504316"},{"key":"e_1_3_4_174_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04280497?term=NCT04280497"},{"key":"e_1_3_4_175_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05785442?term=NCT05785442"},{"key":"e_1_3_4_176_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04990232?term=NCT04990232"},{"key":"e_1_3_4_177_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05531149?term=NCT05531149"},{"key":"e_1_3_4_178_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06294600?term=NCT06294600"},{"key":"e_1_3_4_179_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06225258?term=NCT06225258"},{"key":"e_1_3_4_180_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05843786?term=NCT05843786"},{"key":"e_1_3_4_181_1","unstructured":"ISRCTN. 2026 [cited 2026 Feb 9]. Available from:https:\/\/www.isrctn.com\/ISRCTN10449048"},{"key":"e_1_3_4_182_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06989892?term=NCT06989892"},{"key":"e_1_3_4_183_1","unstructured":"Clinicaltrials.gov. 2025 [cited 2025 Nov 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06694701?term=NCT06694701"},{"key":"e_1_3_4_184_1","unstructured":"ISRCTN. 2026 [cited 2026 Feb 8]. Available from:https:\/\/www.isrctn.com\/ISRCTN80791572"},{"key":"e_1_3_4_185_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10485"},{"key":"e_1_3_4_186_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06871-2"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2646192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:12:34Z","timestamp":1774530754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2026.2646192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"alternative-id":["10.1080\/14787210.2026.2646192"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2026.2646192","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}